SMN1 and proximal spinal muscular atrophy: The NBS methodologies implemented allow for the detection of homozygous deletions in SMN1 corresponding to about 95% of SMA patients, but about 3–5% of patients may be missed due to the presence of subtle mutations along the SMN1 gene [26,30,31].